What We Offer

Current studies:

MAPS' Phase III clinical trials using MDMA-assisted therapy for moderate to severe PTSD

MAPS_edited.png

Upcoming studies:

MDMA-assisted therapy as a treatment for Post Traumatic Stress in COVID-19 Frontline Healthcare Workers